blue cross blue shield reverse course on glp 1 A handful of nonprofit and insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of BCBSM pulling back on GLP-1
Description
Muscle preservation

Compounded GLP-1 now eligible We now accept HFA/FSA

What should patients, physicians, insurers, policy makers, and researchers know about GLP-1 cost, access, and safety
Simply take one tasteless capsule twice daily before breakfast and dinner to start seeing results in as little as four weeks
Goldman Sachs forecasts that the global weight-loss drug market will reach USD 114 billion by 2030, an upward revision of 13% from last years estimate

Yes Data for this study were extracted from the published literature
